University of Padova Hosts Danish Medicines Agency for REDDIE Project Technical Meeting

On July 10-12, 2024, partners from the Università degli Studi di Padova (UNIPD) hosted Dr Tirdad Seifi Ala, the esteemed partner of the Danish Medicines Agency (Lægemiddelstyrelsen, DMA), for an in-depth technical meeting. This visit was a significant milestone in their ongoing collaboration. It provided an excellent opportunity to delve into the details of the current activities in Work Package 5 (WP5), titled "Advanced Methodological Frameworks for Enhancing Clinical Trials with Real-World and Virtual Evidence."

The WP5 is led by UNIPD under the supervision of Principal Investigator Dr Martina Vettoretti, with active involvement from both UNIPD and DMA. The UNIPD team shared their latest developed methodologies, focused on predictive models for the progression of chronic diseases and the conduction of retrospective observational studies. The discussions were highly productive and insightful. Dr Seifi Ala provided valuable feedback and shared his expertise, which helped refine the approaches and identify new avenues for future research. The collaborative atmosphere facilitated a deeper understanding of the challenges and opportunities in leveraging real-world evidence to enhance clinical trials.

The meeting strengthened the UNIPD and DMA partnership in their joint efforts to enhance the use of real-world evidence for complementing randomized controlled trials to improve the efficacy, safety, and cost-effectiveness of technologies designed to prevent and treat diabetes, ultimately benefiting patients and healthcare systems alike.

From left to right: Erica Tavazzi, PhD, Dr Martina Vettoretti, Dr Tirdad Seifi Ala, Enrico Longato, Sara Poletto